Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
Objective To assess the daily and weight-adjusted dosages of hydroxychloroquine (HCQ) and the effects on long-term remission in the Lupus-Cruces cohort.Methods Observational study of routine clinical care data. We selected inception patients treated with HCQ with at least 5 years of follow-up. Prolo...
Saved in:
| Main Authors: | Guillermo Ruiz-Irastorza, Daniel Martín-Iglesias, Ioana Ruiz-Arruza, Fernando Arizpe, Victor Moreno-Torres, Diana Paredes-Ruiz, Valerio Campos-Rodriguez, Laura Amo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/12/1/e001254.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
Published: (2025-04-01) -
Long-term efficacy and safety of the Lupus-Cruces Nephritis protocol: a propensity score study of the Lupus-Cruces and Lupus-Bordeaux cohorts
by: Guillermo Ruiz-Irastorza, et al.
Published: (2025-05-01) -
Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
by: Alberto Floris, et al.
Published: (2018-01-01) -
Protein for Preterm Infants: How Much is Needed? How Much is Enough? How Much is Too Much?
by: William W. Hay, et al.
Published: (2010-08-01) -
Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
by: Tomoo Kise, et al.
Published: (2023-01-01)